Single Use Support - Cold Chain

eBooks

Gummies: A Modern Dosage Solution

Healthcare is undergoing a transformation toward patient-centric solutions, where ease of use, accessibility, and compliance are just as important as therapeutic effectiveness.

Unlock the Future of 3D Cell Analysis — From Isolation to Insight

Explore how automation and live-cell technologies are revolutionizing 3D culture workflows for organoids and iPSCs.

Unlocking New Possibilities with Automated Single-Cell Isolation

Discover how image-based automation tools like CellCelector streamline single-cell isolation, boost productivity, and improve research outcomes. Download the free Sartorius ebook now.

The Ultimate Guide to Choosing the Right Lab Balance

Make smarter, more sustainable purchasing decisions with expert-backed insights.

Efficient Sterility Testing with Compendial Growth-Based & Rapid Real-Time PCR Solutions

Sterility testing is critical to ensuring that sterile products, such as pharmaceuticals and medical devices, are free of contaminating viable microorganisms.

Mastering Advanced Cell Cultures with Superior Media and Live-Cell Insights

Unlock the secrets to high-performing cell cultures with our comprehensive eBook, Mastering Advanced Cell Cultures.

Accelerating Small Molecule Advancements

The increasing number of breakthroughs in small molecule drug development are exciting, but corresponding workflows are complex and require much more tailored approaches to ensure successful upstream and downstream processing, drug approvals and commercialization.

Lab Weighing: Achieve Pharma Compliance with Ease

Matching the ever-demanding regulatory needs of the pharmaceutical industry can be challenging and introducing fully compliant instrumentation and protocols into your lab is a huge step in the right direction.

How top pharma are constructing their next model of clinical development

According to Grandview Research, the hybrid and decentralized clinical trial (DCT) market will be worth more than 12 billion dollars by 2030.